What is Prothena Corp PLC (PRTA)?
Prothena Corporation PLC is a biotechnology company focused on the discovery and development of therapies for neurodegenerative and rare diseases. The company specializes in protein dysregulation and immunology, aiming to develop treatments that address the underlying causes of conditions such as amyloidosis and neurodegenerative disorders. Prothena's research and development efforts include monoclonal antibodies and other biologics designed to target misfolded proteins and pathological aggregates. The company collaborates with academic institutions, pharmaceutical partners, and research organizations to advance its pipeline of therapeutic candidates. Prothena's operations encompass drug discovery, clinical development, and commercialization activities. It contributes to the biopharmaceutical industry by advancing innovative approaches to address unmet medical needs in complex diseases.
Prothena Corp PLC Stock Price Today: Live Overview
The price today is shaped by trading dynamics with Direxion Daily CSI China Internet Bull 2X Shares currently at $8.78. The daily trading range spans between $8.4 and $8.73 with a change of +2.4706%.
FAQ: Prothena Corp PLC (PRTA)
What is the current price of PRTA stock?
The current value is $8.78.
Does PRTA pay dividends?
No dividends are paid by the company.
Does PRTA have a formal corporate presence or regional headquarters in the UAE?
Prothena Corp PLC operates through partners and distributors in the UAE without a direct regional office.
What is PRTA best known for?
It is most famous for its biotechnology research focused on neurodegenerative diseases.
What assets are typically shown together with PRTA?
Commonly shown alongside PRTA: Fast Retailing Co., Ltd., Choice Hotels International Inc, V2X Inc
Latest shares articles



